StockGuru News: New HealthSonix Medical Device Registered With the FDA

New HealthSonix Medical Device Registered With the FDA HealthSonix Inc. (OTC: HSXI) IRVINE, CA–(MARKET WIRE)–Oct 4, 2006 — HealthSonix, Inc. (Other OTC:HSXI.PK – News) (Frankfurt:H7S.F – News) is pleased to announce that its new enSonix@home personal treatment device has been registered and cleared with the United States Food and Drug Administration (FDA), and has been designated as a class1 device, the safest classification for medical devices. The enSonix@home has been indicated for pain reduction and muscle relaxation. “48,000,000 Americans suffer from arthritis pain. With this new medical device, we offer our customers affordable, effective arthritis pain relief without side effects. Patients can use it in the comfort of their own homes. enSonix@home therapy is especially effective when used in combination with the most popular pain relievers. There is an incremental therapeutic benefit when you combine therapies,” said Dieter Doederlein, Vice President of Corporate Development. “Arthritis is still the number one cause of chronic pain in North America and the HealthSonix breakthrough medical technology is very timely as the population segment most susceptible to arthritis will double over the next 20 years.” The enSonix@home device is available in limited quantities presently and will be launched commercially in first quarter of 2007. It retails for $150 and will be marketed directly to consumers through direct response infomercials and direct to consumer advertising through AARP and Arthritis Today consumer publications. The sound pressure waves generated by the enSonix@home medical device are believed to work in three ways: they stimulate mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); they create an exercise effect in the muscles, which encourages the production and release of endorphins, the body’s natural pain killers; and they increase blood circulation. About HealthSonix, Inc. HealthSonix, Inc. (Other OTC:HSXI.PK – News) (Frankfurt:H7S.F – News) is a publicly traded medical technology company. The Company’s core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects. More information regarding HealthSonix and its products and services can be found at: www.HealthSonix.com or by calling the company at 1-877-622-2121. Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties. Contact: Contact: Dieter Doederlein 1-877-622-2121 http://www.healthsonix.com Source: HealthSonix, Inc. View the StockGuru Profile for HealthSonix: http://www.stockguru.com/profiles/hsxi/ We Invite you to Visit the All New StockGuru Blog! Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks. Click HERE to visit the Blog, or go to: http://stockguru.com/blog/ StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $12,500 from a non controlling thrid party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.